Durham, NC, United States of America

Masayuki Kuraoka

USPTO Granted Patents = 2 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2015-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Masayuki Kuraoka: Innovator in HIV Immunology

Introduction: Masayuki Kuraoka, an accomplished inventor based in Durham, NC, has made significant contributions to the field of immunology. His innovative work focuses particularly on enhancing immune responses to human immunodeficiency virus (HIV-1), aiming to improve treatment strategies for this global health challenge. With a patent to his name, Kuraoka’s research reflects a commitment to advancing scientific understanding and medical applications.

Latest Patents: Kuraoka holds a patent for an adjuvant related to HIV-1 immunization. This invention outlines a novel method for enhancing immune responses to HIV-1 immunogens and includes various compounds and compositions suited for this purpose. This patent exemplifies his dedication to combating HIV through innovative approaches that could potentially lead to more effective vaccines and therapies.

Career Highlights: Masayuki Kuraoka is affiliated with Duke University, where he conducts his influential research. His role at the university allows him to collaborate with esteemed professionals in the field, furthering his impact on immunology and vaccine development.

Collaborations: Throughout his career, Kuraoka has worked closely with renowned scientists such as Barton F. Haynes and Laurent Verkoczy. These collaborations foster a rich environment for innovation, combining expertise to tackle complex challenges in the realm of HIV research and vaccine development.

Conclusion: Masayuki Kuraoka’s work exemplifies the vital role of inventors in addressing public health issues. His focus on enhancing immune responses to HIV-1 not only contributes to scientific knowledge but also holds promise for future therapeutic advancements. As researchers like Kuraoka continue to innovate, the pursuit of effective solutions to infectious diseases remains a critical undertaking.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…